T1	PROC 44 73	Estudio abierto de dos grupos
T2	CHEM 87 100	rilzabrutinib
T3	LIVB 104 113	pacientes
#1	AnnotatorNotes T3	C0030705; Patients; Patient or Disabled Group
T4	DISO 118 152	enfermedad relacionada con la IgG4
T5	PROC 173 217	Estudio de fase IIa, abierto y de dos grupos
T6	CHEM 244 257	rilzabrutinib
T8	DISO 318 328	enfermedad
#2	AnnotatorNotes T8	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T9	LIVB 332 341	pacientes
#3	AnnotatorNotes T9	C0030705; Patients; Patient or Disabled Group
T10	DISO 346 380	enfermedad relacionada con la IgG4
T12	CHEM 433 451	inmunoglobulina G4
#5	AnnotatorNotes T12	C0020860; Immunoglobulin IgG4; Amino Acid, Peptide, or Protein · Immunologic Factor
T15	LIVB 543 549	hombre
#7	AnnotatorNotes T15	C0025266; Male population group; Population Group | C0086418; Homo sapiens; Human
T16	LIVB 552 557	mujer
#8	AnnotatorNotes T16	C0043210; Woman; Population Group | C0242665; wife; Family Group
T17	Age 567 575	≥18 años
T18	PROC 589 608	diagnóstico clínico
#9	AnnotatorNotes T18	C0332140; Diagnosis, clinical; Finding
T19	DISO 612 619	IgG4-RD
T20	PROC 642 661	disminuir una dosis
T21	Dose 652 661	una dosis
T22	CHEM 677 687	prednisona
#10	AnnotatorNotes T22	C0032952; prednisone; Hormone · Organic Chemical · Pharmacologic Substance
T23	Dose 694 702	20-40 mg
T24	Frequency 702 706	/día
T25	Duration 710 719	2 semanas
T26	Date 748 759	Actualmente
T27	Duration 772 783	los 6 meses
T28	CHEM 819 828	rituximab
#11	AnnotatorNotes T28	C0393022; rituximab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T30	ANAT 860 869	células B
#12	AnnotatorNotes T30	C0004561; B-Lymphocytes; Cell
T31	CHEM 872 891	agentes alquilantes
#13	AnnotatorNotes T31	C0002073; Alkylating Agents; Hazardous or Poisonous Substance · Pharmacologic Substance
T33	ANAT 1010 1017	células
#14	AnnotatorNotes T33	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T34	PROC 1042 1061	citometría de flujo
#15	AnnotatorNotes T34	C0016263; Flow Cytometry; Laboratory Procedure
T35	PROC 1079 1106	trasplante de órgano sólido
T36	PROC 1125 1144	prueba de detección
T37	DISO 1148 1151	VIH
#16	AnnotatorNotes T37	C0458074; Human immunodeficiency virus (HIV) status; Finding
T38	DISO 1153 1164	hepatitis B
#17	AnnotatorNotes T38	C0019163; Hepatitis B; Disease or Syndrome
T39	DISO 1166 1177	hepatitis C
#18	AnnotatorNotes T39	C0019196; Hepatitis C; Disease or Syndrome
T40	DISO 1180 1182	TB
#19	AnnotatorNotes T40	C0005586; Bipolar Disorder; Mental or Behavioral Dysfunction | C0040586; Tracheobronchitis; Disease or Syndrome | C0041296; Tuberculosis; Disease or Syndrome
T41	LIVB 1186 1193	Mujeres
#20	AnnotatorNotes T41	C0043210; Woman; Population Group | C0242665; wife; Family Group
T42	PHYS 1218 1229	amamantando
#21	AnnotatorNotes T42	C0006147; Breast Feeding; Organism Function
T13	DISO 476 510	Enfermedad relacionada con la IgG4
T14	CHEM 148 152	IgG4
T43	CHEM 376 380	IgG4
T11	DISO 403 451	Enfermedad relacionada con la inmunoglobulina G4
T44	CHEM 506 510	IgG4
T45	PHYS 1204 1215	embarazadas
T29	CHEM 836 843	agentes
T46	CHEM 259 266	PRN1008
T7	CHEM 267 276	SAR444671
